From the archive record
Nicholas Piramal Tower belongs to Piramal Group a diversified conglomerate with operations in over 30 countries and a brand-presence across 100 markets around the world. Since the late 1980s, the Piramal Group has evolved from a textile-centric business to a diversified organization, which operates across sectors such as healthcare, life sciences, healthcare information management, financial services, specialty glass packaging and real estate. As a Group they have consistently identified opportunities ahead of the curve, even when market situations suggest the opposite. They invested in the domestic formulations business when others were focused on growing international generics. Their persistence paid off when a deal with Abbott in 2010 valued our business at USD 3.72 billion, an unpreced